Economic portfolio
Bandhan Healthcare Fund
BANDHAN Bandhan Mutual Fund Nov 2025 — Sep 2026 11 months
Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →
Days to sell half: 0.9 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Quick to unwind on normal volumes. Small-cap comparison →
Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.
How concentrated it has been
11 priced months, Nov 2025 to Sep 2026 · at each month’s NSE closes
Top 10 holdings, share of equity
54.5% now · highest 73.1%, lowest 53.7%
Companies held
35 now · largest single holding 10.4% of equity
How it trades: no clear lean toward recent winners or losers (score -0.15 over 6 months; −1 always buys the biggest fallers, +1 the biggest risers, 0 no pattern). Value and contra funds average −0.10, other active funds about 0. A description of behaviour, not of results. How this was tested →
Sector mix
Share of the equity shown · NSE industry
Funds most like this one
Overlap of disclosed equity · the smaller share of each company both hold, added up
- EODWHFEdelweiss · 17 shared61.1%
- Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 21 shared61.0%
- Motilal Oswal BSE Healthcare ETFMotilal Oswal · 34 shared59.8%
- Bandhan BSE Healthcare Index FundBandhan · 34 shared59.8%
- Axis NIFTY Healthcare ETFAxis · 13 shared57.8%
- ICICI Prudential Nifty Healthcare ETFICICI Prudential · 13 shared57.8%
- DSP Nifty Healthcare Index FundDSP · 13 shared57.8%
- DSP Nifty Healthcare ETFDSP · 13 shared57.8%
Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.
What changed in Sep 2026
This portfolio’s consecutive disclosures · evidenced adjustments applied
New positions
- None this month.
Complete exits
- None this month.
Largest increases
Largest reductions
Share quantities, not market values or cash flows.
Holdings by value
Sep 2026 · largest 100 · share of the equity shown
| Company | Sector | Size | Share of equity | Value | Shares held | Held since |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Healthcare | Large Cap | 10.41% | 31.79 Cr | 0.02 Cr | by Nov 2025 (11 mo+) |
| Cipla Limited | Healthcare | Large Cap | 6.61% | 20.19 Cr | 0.01 Cr | by Nov 2025 (11 mo+) |
| Apollo Hospitals Enterprise Limited | Healthcare | Large Cap | 6.15% | 18.78 Cr | 23,000 | by Nov 2025 (11 mo+) |
| Max Healthcare Institute Limited | Healthcare | Large Cap | 5.63% | 17.20 Cr | 0.02 Cr | by Nov 2025 (11 mo+) |
| Lupin Limited | Healthcare | Mid Cap | 4.65% | 14.21 Cr | 70,000 | Dec 2025 (10 mo) |
| Divi's Laboratories Limited | Healthcare | Large Cap | 4.56% | 13.94 Cr | 15,000 | by Nov 2025 (11 mo+) |
| Shilpa Medicare Limited | Healthcare | Small Cap | 4.46% | 13.61 Cr | 0.01 Cr | Dec 2025 (10 mo) |
| Aurobindo Pharma Limited | Healthcare | Mid Cap | 4.38% | 13.38 Cr | 80,000 | by Nov 2025 (11 mo+) |
| Dr. Reddy's Laboratories Limited | Healthcare | Large Cap | 4.04% | 12.33 Cr | 0.01 Cr | by Nov 2025 (11 mo+) |
| GlaxoSmithKline Pharmaceuticals Limited | Healthcare | Mid Cap | 3.63% | 11.08 Cr | 40,000 | by Nov 2025 (11 mo+) |
| Torrent Pharmaceuticals Limited | Healthcare | Large Cap | 3.46% | 10.56 Cr | 22,000 | Jul 2026 (3 mo) |
| Gland Pharma Limited | Healthcare | Small Cap | 3.32% | 10.15 Cr | 35,000 | Aug 2026 (2 mo) |
| Zydus Lifesciences Limited | Healthcare | Mid Cap | 3.02% | 9.22 Cr | 79,327 | May 2026 (5 mo) |
| Narayana Hrudayalaya Ltd. | Healthcare | Mid Cap | 2.93% | 8.96 Cr | 50,000 | May 2026 (5 mo) |
| Syngene International Limited | Healthcare | Small Cap | 2.63% | 8.04 Cr | 0.02 Cr | by Nov 2025 (11 mo+) |
| Rainbow Childrens Medicare Limited | Healthcare | Small Cap | 2.37% | 7.23 Cr | 55,000 | by Nov 2025 (11 mo+) |
| Eris Lifesciences Limited | Healthcare | Small Cap | 2.34% | 7.15 Cr | 60,000 | Apr 2026 (6 mo) |
| Glenmark Pharmaceuticals Limited | Healthcare | Mid Cap | 2.29% | 7.00 Cr | 30,000 | by Nov 2025 (11 mo+) |
| Global Health Limited | Healthcare | Mid Cap | 2.01% | 6.14 Cr | 45,000 | Dec 2025 (10 mo) |
| Novartis India Limited | Not classified | Small Cap | 2.01% | 6.13 Cr | 31,934 | May 2026 (5 mo) |
| Pfizer Limited | Healthcare | Small Cap | 1.65% | 5.04 Cr | 13,000 | by Nov 2025 (11 mo+) |
| Sanofi India Limited | Not classified | Small Cap | 1.60% | 4.89 Cr | 16,000 | Dec 2025 (10 mo) |
| IPCA Laboratories Limited | Healthcare | Mid Cap | 1.58% | 4.82 Cr | 25,000 | Feb 2026 (8 mo) |
| Healthcare Global Enterprises Limited | Healthcare | Small Cap | 1.42% | 4.33 Cr | 65,000 | Dec 2025 (10 mo) |
| Thyrocare Technologies Limited | Healthcare | Small Cap | 1.40% | 4.27 Cr | 80,000 | Apr 2026 (6 mo) |
| Jubilant Pharmova Limited | Healthcare | Small Cap | 1.35% | 4.12 Cr | 40,000 | Aug 2026 (2 mo) |
| Ajanta Pharma Limited | Healthcare | Small Cap | 1.30% | 3.98 Cr | 11,000 | by Nov 2025 (11 mo+) |
| Sai Life Sciences Limited | Healthcare | Small Cap | 1.25% | 3.81 Cr | 25,000 | by Nov 2025 (11 mo+) |
| Sai Parenterals Limited | Not classified | — | 1.23% | 3.75 Cr | 70,830 | Jul 2026 (3 mo) |
| Alivus Life Sciences Limited | Not classified | Small Cap | 1.23% | 3.75 Cr | 27,172 | May 2026 (5 mo) |
| AstraZeneca Pharma India Limited | Not classified | Small Cap | 1.22% | 3.71 Cr | 6,000 | Aug 2026 (2 mo) |
| Orchid Pharma Limited | Not classified | Small Cap | 1.21% | 3.69 Cr | 37,000 | Dec 2025 (10 mo) |
| Dr. Lal Path Labs Ltd. | Healthcare | Small Cap | 0.98% | 2.98 Cr | 15,000 | by Nov 2025 (11 mo+) |
| Medi Assist Healthcare Services Limited | Not classified | Small Cap | 0.89% | 2.72 Cr | 90,000 | Dec 2025 (10 mo) |
| Viyash Scientific Limited | Healthcare | Small Cap | 0.83% | 2.53 Cr | 0.01 Cr | Jun 2026 (4 mo) |
Half of its current holdings have been held for 10 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.
Recent position changes
Latest 100 company-month records · evidenced adjustments applied
| Company | Month | Activity | Adjusted change |
|---|---|---|---|
| Syngene International Limited | Sep 2026 | ▲ Increasing | +20,000 |
| Jubilant Pharmova Limited | Sep 2026 | ▼ Reducing | -15,000 |
| Sai Parenterals Limited | Sep 2026 | ▲ Increasing | +10,000 |
| Healthcare Global Enterprises Limited | Sep 2026 | ▼ Reducing | -10,000 |
| Global Health Limited | Sep 2026 | ▼ Reducing | -10,000 |
| Lupin Limited | Sep 2026 | ▲ Increasing | +10,000 |
| Narayana Hrudayalaya Ltd. | Sep 2026 | ▲ Increasing | +5,000 |
| Ajanta Pharma Limited | Sep 2026 | ▼ Reducing | -5,000 |
| Alivus Life Sciences Limited | Sep 2026 | ▼ Reducing | -5,000 |
| Rainbow Childrens Medicare Limited | Sep 2026 | ▲ Increasing | +5,000 |
| Apollo Hospitals Enterprise Limited | Sep 2026 | ▲ Increasing | +2,000 |
| Max Healthcare Institute Limited | Aug 2026 | ▲ Increasing | +85,000 |
| Jubilant Pharmova Limited | Aug 2026 | ▲ New position | +55,000 |
| Dr. Lal Path Labs Ltd. | Aug 2026 | ▼ Reducing | -43,000 |
| Syngene International Limited | Aug 2026 | ▲ Increasing | +40,000 |
| Lupin Limited | Aug 2026 | ▲ Increasing | +37,500 |
| Gland Pharma Limited | Aug 2026 | ▲ New position | +35,000 |
| Global Health Limited | Aug 2026 | ▼ Reducing | -27,000 |
| Healthcare Global Enterprises Limited | Aug 2026 | ▼ Reducing | -25,000 |
| Narayana Hrudayalaya Ltd. | Aug 2026 | ▲ Increasing | +20,000 |
| Glenmark Pharmaceuticals Limited | Aug 2026 | ▼ Reducing | -20,000 |
| Orchid Pharma Limited | Aug 2026 | ▼ Reducing | -18,000 |
| Eris Lifesciences Limited | Aug 2026 | ▲ Increasing | +14,727 |
| Ajanta Pharma Limited | Aug 2026 | ▼ Reducing | -11,000 |
| IPCA Laboratories Limited | Aug 2026 | ▼ Reducing | -10,000 |
| Concord Biotech Limited | Aug 2026 | ▼ Complete exit | -10,000 |
| GlaxoSmithKline Pharmaceuticals Limited | Aug 2026 | ▲ Increasing | +10,000 |
| Viyash Scientific Limited | Aug 2026 | ▲ Increasing | +10,000 |
| Apollo Hospitals Enterprise Limited | Aug 2026 | ▼ Reducing | -9,000 |
| Torrent Pharmaceuticals Limited | Aug 2026 | ▼ Reducing | -6,050 |
| AstraZeneca Pharma India Limited | Aug 2026 | ▲ New position | +6,000 |
| Sai Life Sciences Limited | Aug 2026 | ▼ Reducing | -5,000 |
| Sai Parenterals Limited | Aug 2026 | ▲ Increasing | +4,180 |
| Abbott India Limited | Aug 2026 | ▼ Complete exit | -2,500 |
| Sanofi India Limited | Aug 2026 | ▲ Increasing | +2,035 |
| Divi's Laboratories Limited | Aug 2026 | ▼ Reducing | -1,000 |
| Max Healthcare Institute Limited | Jul 2026 | ▼ Reducing | -80,000 |
| Star Health and Allied Insurance Company Limited | Jul 2026 | ▼ Complete exit | -80,000 |
| J.B. Chemicals & Pharmaceuticals Lt | Jul 2026 | ▼ Complete exit | -60,000 |
| Sai Parenterals Limited | Jul 2026 | ▲ New position | +56,650 |
| Viyash Scientific Limited | Jul 2026 | ▲ Increasing | +55,000 |
| Thyrocare Technologies Limited | Jul 2026 | ▲ Increasing | +40,000 |
| Syngene International Limited | Jul 2026 | ▲ Increasing | +30,000 |
| Torrent Pharmaceuticals Limited | Jul 2026 | ▲ New position | +28,050 |
| Novartis India Limited | Jul 2026 | ▲ Increasing | +21,958 |
| Shilpa Medicare Limited | Jul 2026 | ▼ Reducing | -20,000 |
| Divi's Laboratories Limited | Jul 2026 | ▼ Reducing | -14,000 |
| Global Health Limited | Jul 2026 | ▲ Increasing | +12,000 |
| Concord Biotech Limited | Jul 2026 | ▼ Reducing | -10,000 |
| Inventurus Knowledge Solutions Limited | Jul 2026 | ▼ Complete exit | -5,000 |
| Sanofi India Limited | Jul 2026 | ▲ Increasing | +1,965 |
| Viyash Scientific Limited | Jun 2026 | ▲ New position | +42,236 |
| Mankind Pharma Limited | Jun 2026 | ▼ Complete exit | -25,000 |
| Sun Pharmaceutical Industries Limited | Jun 2026 | ▲ Increasing | +25,000 |
| Max Healthcare Institute Limited | Jun 2026 | ▼ Reducing | -22,500 |
| Dr. Reddy's Laboratories Limited | Jun 2026 | ▼ Reducing | -20,000 |
| Aurobindo Pharma Limited | Jun 2026 | ▲ Increasing | +20,000 |
| J.B. Chemicals & Pharmaceuticals Lt | Jun 2026 | ▼ Reducing | -5,000 |
| GlaxoSmithKline Pharmaceuticals Limited | Jun 2026 | ▲ Increasing | +5,000 |
| Apollo Hospitals Enterprise Limited | Jun 2026 | ▼ Reducing | -3,000 |
| Ajanta Pharma Limited | Jun 2026 | ▼ Reducing | -3,000 |
| Novartis India Limited | Jun 2026 | ▲ Increasing | +2,000 |
| Zydus Lifesciences Limited | Jun 2026 | ▼ Reducing | -673 |
| Abbott India Limited | Jun 2026 | ▲ Increasing | +300 |
| Zydus Lifesciences Limited | May 2026 | ▲ New position | +80,000 |
| Krishna Institute of Medical Sciences Limited | May 2026 | ▼ Complete exit | -80,000 |
| Aster DM Quality Care Limited | May 2026 | ▼ Complete exit | -60,000 |
| Healthcare Global Enterprises Limited | May 2026 | ▲ Increasing | +56,126 |
| Alivus Life Sciences Limited | May 2026 | ▲ New position | +32,172 |
| Jubilant Pharmova Limited | May 2026 | ▼ Complete exit | -30,000 |
| Thyrocare Technologies Limited | May 2026 | ▲ Increasing | +30,000 |
| Blue Jet Healthcare Limited | May 2026 | ▼ Complete exit | -30,000 |
| Cohance Lifesciences Limited | May 2026 | ▼ Complete exit | -30,000 |
| IPCA Laboratories Limited | May 2026 | ▲ Increasing | +25,000 |
| Shilpa Medicare Limited | May 2026 | ▲ Increasing | +25,000 |
| Narayana Hrudayalaya Ltd. | May 2026 | ▲ New position | +25,000 |
| Glenmark Pharmaceuticals Limited | May 2026 | ▲ Increasing | +22,000 |
| Orchid Pharma Limited | May 2026 | ▲ Increasing | +20,000 |
| Mankind Pharma Limited | May 2026 | ▼ Reducing | -20,000 |
| Lupin Limited | May 2026 | ▼ Reducing | -12,500 |
| Eris Lifesciences Limited | May 2026 | ▲ Increasing | +10,000 |
| Medi Assist Healthcare Services Limited | May 2026 | ▲ Increasing | +10,000 |
| Dr. Reddy's Laboratories Limited | May 2026 | ▼ Reducing | -10,000 |
| Sai Life Sciences Limited | May 2026 | ▼ Reducing | -10,000 |
| Novartis India Limited | May 2026 | ▲ New position | +7,976 |
| Rainbow Childrens Medicare Limited | May 2026 | ▲ Increasing | +5,000 |
| Divi's Laboratories Limited | May 2026 | ▼ Reducing | -4,000 |
| Pfizer Limited | May 2026 | ▲ Increasing | +3,000 |
| GlaxoSmithKline Pharmaceuticals Limited | May 2026 | ▲ Increasing | +3,000 |
| Sanofi India Limited | May 2026 | ▲ Increasing | +2,000 |
| Eris Lifesciences Limited | Apr 2026 | ▲ New position | +35,273 |
| Cohance Lifesciences Limited | Apr 2026 | ▼ Reducing | -30,000 |
| Dr. Reddy's Laboratories Limited | Apr 2026 | ▼ Reducing | -25,000 |
| Orchid Pharma Limited | Apr 2026 | ▲ Increasing | +11,012 |
| Lupin Limited | Apr 2026 | ▼ Reducing | -10,000 |
| Glenmark Pharmaceuticals Limited | Apr 2026 | ▼ Reducing | -10,000 |
| Sai Life Sciences Limited | Apr 2026 | ▼ Reducing | -10,000 |
| Thyrocare Technologies Limited | Apr 2026 | ▲ New position | +10,000 |
| Onesource Specialty Pharma Limited | Mar 2026 | ▼ Complete exit | -25,000 |
| J.B. Chemicals & Pharmaceuticals Lt | Mar 2026 | ▼ Reducing | -15,000 |
Changes compare consecutive month-end disclosures for this portfolio only.